The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 13, 2015
Filed:
Jun. 28, 2011
Applicants:
Rakesh K. Jain, Wellesley, MA (US);
Dan G. Duda, Belmont, MA (US);
Sergey V. Kozin, Cambridge, MA (US);
Dai Fukumura, Newton, MA (US);
Inventors:
Rakesh K. Jain, Wellesley, MA (US);
Dan G. Duda, Belmont, MA (US);
Sergey V. Kozin, Cambridge, MA (US);
Dai Fukumura, Newton, MA (US);
Assignee:
THE GENERAL HOSPITAL CORPORATION, Boston, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); A61K 31/395 (2006.01); A61K 45/06 (2006.01); A61K 31/404 (2006.01); A61K 31/44 (2006.01); A61K 31/517 (2006.01); A61K 39/395 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/395 (2013.01); A61K 31/404 (2013.01); A61K 31/44 (2013.01); A61K 31/517 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 38/00 (2013.01);
Abstract
Inhibition of CXCR4 can inhibit tumor growth and metastasis during certain therapeutic windows. Disclosed are novel methods for treating and preventing cancer in a subject related to administration of CXCR4 inhibitors during a therapeutic window following treatment with another anti-tumor therapy.